ClinicalTrials.Veeva

Menu

Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy

N

Nabil Mahmoud Ismail Abdel-Aal

Status

Unknown

Conditions

Thyroid Cancer

Treatments

Device: X-BOX kinetic360
Drug: thyroid hormone replacement therapy
Dietary Supplement: mediterranean diet

Study type

Interventional

Funder types

Other

Identifiers

NCT05265819
P.T.REC/012/003356

Details and patient eligibility

About

Effect of exergaming exercises and mediteranean diet on thyroid cancer patients following total thyroidectomy adult patients from both gender will be randomly assigned equally to exergaming exercises, Mediterranean diet groups using computer-generated block randomization.

Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed three times a week, for a total of 12 weeks Group C: Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.PREDIMED questionnaire is used To assess adherence to the Mediterranean diet Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet

Full description

Outcome measures

  1. Flow cytometry analyzer for NKC (CD3- CD16+ CD56+).
  2. Immunoassay analyzer for thyroid profile (TSH,T3,T4)
  3. Quality of life questionnaire
  4. Fatigue questionnaire
  5. PREDIMED questionnaire to asses diet adherence. Outcome measures will be measured at baseline and after 3 months of the treatement intervention

A) assessment

  1. Quality of life questionnaire questionnaire

  2. .Fatigue questionnaire

  3. Adherence to diet A validated 14-item questionnaire for the assessment of adherence to the Mediterranean Diet (PREDIMED) will be recorded for all the enrolled subjects

    • Biochemical Analysis. [B] Intervention

      1. Exergaming The practice of exergaming was performed using the Xbox 360 Kinect console (Microsoft, Albuquerque, NM)
      2. Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.

      4 groups will be randomly assigned Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions, with progressive increase in the duration of the games according to their tolerance,and reached a maximum duration of 50 minutes per session, included the realization of the games and the rest between activities. The exergaming protocol was performed three times a week, for a total of 12 weeks Group C: Mediterranean diet All participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.PREDIMED questionnaire is used To assess adherence to the Mediterranean diet Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet

Enrollment

80 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Diagnosis of thyroid papillary carcinoma as it is the most common type

  2. Treatment with thyroid hormone medication after thyroidectomy

  3. Lack of radioactive iodine treatment within the past 6 months

  4. Blood hemoglobin level >10 g/dL.

  5. Not taking drugs that could affect their immune function (e.g., immunosuppressants such as cyclosporin and steroids .

  6. Lack of regular exercise

  7. Age 18~45 years

  8. Dose should be controlled at the first one year

    Exclusion Criteria:

  1. Abscess or inflammation suspected by preoperative tests 2) Patients with stage IV cancer and with limited understanding of assessment systems 3) History of head or neck malignancy . 4) Radiation therapy 5) Graves disease 6) Thyroiditis 7) Orthopaedic and rheumatic conditions of the neck . 8) The patient's inability to cooperate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 4 patient groups

Group A
Active Comparator group
Description:
Group A: Control group No intervention was provided for 12 weeks except thyroid hormone replacement therapy
Treatment:
Drug: thyroid hormone replacement therapy
Group B
Experimental group
Description:
Group B: Exergaming exercise The volunteers carried out 36 exergaming sessions
Treatment:
Device: X-BOX kinetic360
Group C
Experimental group
Description:
Group C: Mediterranean diet participants participated in the Mediterranean diet intervention for 12 weak and received dietary training from professional nutritionists at the baseline visit and samples of a Mediterranean diet for three times during the trial.
Treatment:
Dietary Supplement: mediterranean diet
Group D
Experimental group
Description:
Group D: Exergaming exercises and Mediterranean diet Exergaming exercises are used in addition to Mediterranean diet
Treatment:
Dietary Supplement: mediterranean diet
Device: X-BOX kinetic360

Trial contacts and locations

0

Loading...

Central trial contact

Nabil M Abdel-Aal, PhD; Mohsen M Elsayyad, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems